MGO Private Wealth LLC Acquires Shares of 399 UnitedHealth Group Incorporated (NYSE:UNH)

MGO Private Wealth LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 399 shares of the healthcare conglomerate’s stock, valued at approximately $209,000.

Several other large investors also recently bought and sold shares of the stock. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter worth about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John H. Noseworthy bought 300 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock valued at $31,607,768 in the last quarter. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Down 0.6%

Shares of UNH opened at $306.90 on Thursday. The firm has a market cap of $278.40 billion, a PE ratio of 12.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44. The company’s fifty day moving average is $370.86 and its two-hundred day moving average is $467.96. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the business posted $6.91 EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.88%. UnitedHealth Group’s payout ratio is 37.02%.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Oppenheimer dropped their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Wall Street Zen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Finally, Raymond James Financial cut shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.